{"nct_id":"NCT06480552","title":"An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2024-07-22","start_date_type":"ACTUAL","primary_completion_date":"2029-05-26","primary_completion_date_type":"ESTIMATED","completion_date":"2031-02-25","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["TEVA"]}